News | BrainReader

News

Latest Company Updates, Partnerships & Industry Announcements

Brainreader Welcomes Dr. Basant Kumar Bajpai as QA/RA Manager

Brainreader Inc., Andrew Grady

Brainreader Welcomes Dr. Basant Kumar Bajpai as QA/RA Manager

Dr. Basant Bajpai, PhD. has recently joined Brainreader as our QA/RA Manager. Dr. Bajpai earned a doctorate in Neuroscience (Brain Monitoring) at Kaunas University of Technology with specialty in Trau...

30. okt. 2025 News

Brainreader and INFINITT North America Announce Strategic Partnership

Brainreader Inc., Andrew Grady

Brainreader and INFINITT North America Announce Strategic Partnership

Media release, Copenhagen, DK and Phillipsburg, NJ – June 9, 2022. INFINITT North America and Brainreader Inc. announced today a wide-ranging and unique partnership to expand and deepen the use of Bra...

30. okt. 2025 News

Brainreader Partners with Phenome Health on Landmark Million-Person Brain Health Trial

Brainreader Inc., Andrew Grady

Brainreader Partners with Phenome Health on Landmark Million-Person Brain Health Trial

Press Release , Copenhagen, Denmark – November 29, 2022 Brainreader Inc. announced today that it is in advanced negotiations to utilize its Neuroreader® software as the sole source of volumetric brain...

30. okt. 2025 News

Brainreader Secures $7.3M to Drive Global Expansion of AI-Powered Brain Diagnostics

Brainreader Inc., Andrew Grady

Brainreader Secures $7.3M to Drive Global Expansion of AI-Powered Brain Diagnostics

Danish medtech company Brainreader A/S has successfully completed a financing round of USD 7.3 million (EUR 6.6 million) to accelerate the global rollout of its AI-driven diagnostic platform Neuroread...

30. okt. 2025 News

Do you want to know more about our software?

Fill out the form below and we will get back to you as soon as possible.

Full Name *

Telefonnummer

Email Address *

Company Name *

Country/Region *

Comments

I would like to receive emails from Brainreader regarding news, updates, offers, and promotions. I understand I may opt out at any time.

Submit